SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-19-006828
Filing Date
2019-03-07
Accepted
2019-03-07 17:00:29
Documents
79
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 2018 10-K snss-10k_20181231.htm 10-K 2570014
2 EX-10.18 snss-ex1018_218.htm EX-10.18 624407
3 EX-21.1 snss-ex211_6.htm EX-21.1 2603
4 EX-23.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM snss-ex231_12.htm EX-23.1 14371
5 EX-31.1 snss-ex311_14.htm EX-31.1 16538
6 EX-31.2 snss-ex312_10.htm EX-31.2 16756
7 EX-32.1 snss-ex321_8.htm EX-32.1 9827
8 GRAPHIC g0lb5hc4g3yj000001.jpg GRAPHIC 23300
  Complete submission text file 0001564590-19-006828.txt   9068728

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT snss-20181231.xml EX-101.INS 1629825
10 XBRL TAXONOMY EXTENSION SCHEMA snss-20181231.xsd EX-101.SCH 73284
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snss-20181231_cal.xml EX-101.CAL 54374
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snss-20181231_def.xml EX-101.DEF 221174
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE snss-20181231_lab.xml EX-101.LAB 514232
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snss-20181231_pre.xml EX-101.PRE 390790
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51531 | Film No.: 19666551
SIC: 2834 Pharmaceutical Preparations